We have previously shown that a combination of AZD2461 and valproic acid, a histone deacetylase inhibitor, activates apoptotic cell death in phosphatase and tensin homolog (PTEN)-deficient prostate cancer cells [85]. Here, PTEN is linked to prostate carcinoma.